NEW YORK (GenomeWeb News) — The National Heart, Lung, and Blood Institute has launched a multi-site clinical trial to assess how African-Americans with asthma respond to different therapies, and to examine the genetics at play in those responses, NHLBI said today.

The Best African American Response to Asthma Drugs (BARD) study will enroll roughly 500 children and adults at 30 sites in 14 states to research their responses to varying combinations of medications and dosages and how genes may affect those responses.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.